4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000899243-15-005095
S.V.P., General Counsel sold 1,129 shares at $6.32 ($7,135)
From the SEC's structured data for this filing
Trades in this filing
Ozeroff Christopher David · S.V.P., General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-09-18 | Sale : show line 1 in the form | −1,129 | $6.32 | $7,135 | 20,409 | D |
| Open-market sales · 1,129 sh · avg $6.32 · $7,135 | ||||||
Loading xslF345X03/doc4.xml…